CN Patent
CN105061373B — 一种达格列净异构体杂质的合成方法
Assigned to Hefei Huafang Pharmaceutical Sciences & Technology Co Ltd · Expires 2017-10-20 · 9y expired
What this patent protects
本发明公开了一种达格列净异构体杂质的合成方法,以2‑氯‑5‑溴苯甲酸为原料,经酰化、付克‑烷基化、羰基还原、缩合、脱甲氧基等反应得到达格列净异构体杂质,为达格列净有关物质的研究提供依据。
USPTO Abstract
本发明公开了一种达格列净异构体杂质的合成方法,以2‑氯‑5‑溴苯甲酸为原料,经酰化、付克‑烷基化、羰基还原、缩合、脱甲氧基等反应得到达格列净异构体杂质,为达格列净有关物质的研究提供依据。
Drugs covered by this patent
- Brenzavvy (BEXAGLIFLOZIN) · Theracosbio
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.